Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: Evidence of improved vascular α1-adrenoreceptor signal transduction
To access this article, please choose from the options below
Funding: GlaxoSmithKline Investigator Initiated Trials.
Conflict of interest: Benjamin W. Van Tassell, none; Matthew Rondina, none; Franklin Huggins, none; Mark A. Munger, GlaxoSmithKline Speakers Bureau and Research Grant Support; Edward M. Gilbert, GlaxoSmithKline Speakers Bureau and Research Grant Support.
PII: S0002-8703(08)00279-2
doi:10.1016/j.ahj.2008.04.004
© 2008 Mosby, Inc. All rights reserved.
